The largest community of pharma leaders

QUE Oncology Appoints Dr. Julie Cherrington and Elizabeth Cermak to Board of Directors

ATLANTA–(BUSINESS WIRE)–QUE Oncology, a clinical-stage biotechnology company developing a novel treatment for breast cancer patients suffering debilitating hot flashes, today announces the appointment of two highly-regarded life science executives to its Board of Directors. Dr. Julie Cherrington and Elizabeth Cermak have been appointed to the board, each bringing decades of experience from both large pharmaceutical and start-up biotechnology companies, with a particular focus on drug… 

Recent Articles